产品介绍:
产品说明
包装
5, 25 mg in glass bottle
生化/生理作用
PKI-166 is a potent, selective and orally available EGF-R tyrosine kinase inhibitor. PKI-166 potently inhibits the growth and metastasis of many human cancers including human pancreatic cancer.
其他说明
Light and air sensitive.
基本信息
经验(实验)分子式 | C20H18N4O |
分子量 | 330.38 |
MDL编号 | MFCD09970842 |
PubChem化学物质编号 | 329825472 |
产品性质
质量水平 | 100 |
测定 | ≥98% (HPLC) |
形式 | powder |
颜色 | white to beige |
溶解性 | DMSO: 10 mg/mL, clear |
储存温度 | 2-8℃ |
SMILES string | OC(C=C1)=CC=C1C2=CC3=C(N2)N=CN=C3N[C@H](C)C4=CC=CC=C4 |
InChI | 1S/C20H18N4O/c1-13(14-5-3-2-4-6-14)23-19-17-11-18(24-20(17)22-12-21-19)15-7-9-16(25)10-8-15/h2-13,25H,1H3,(H2,21,22,23,24)/t13-/m1/s1 |
InChI key | XRYJULCDUUATMC-CYBMUJFWSA-N |
Gene Information | human ... EGFR(1956) |
安全信息
象形图 | |
警示用语: | Danger |
危险声明 | H301 |
预防措施声明 | P301 + P310 |
危险分类 | Acute Tox. 3 Oral |
储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects |
WGK | WGK 3 |
闪点(F) | Not applicable |
闪点(C) | Not applicable |